Results 61 to 70 of about 71,624 (120)

Nobiletin in cancer therapy: Emerging insights into multi-target mechanisms, overcoming drug resistance and therapeutic translation (Review). [PDF]

Oncol Lett
Zhang Y, Li Q, Yu W, He B, Peng J, Yao B.   +5 more
europepmc   +1 more source

NF-κB Signaling in Prostate Cancer Progression: Inflammatory Mediators, Survival Pathways, and Regulatory Axes. [PDF]

Cancers (Basel)
Al-Hakm R, Altaie AM, Boghossian A, Bendardaf R, Talaat IM, Hamoudi R.   +5 more
europepmc   +1 more source

Potential Efficacy of Luteolin in Cutaneous Squamous Cell Carcinoma: A Combined In Vitro and In Vivo Study. [PDF]

Biomolecules
Guo Y, Wang X, Gao Y, Xu Y, Fang Z, Liu S, Dong H, Luo J, Yan L.   +8 more
europepmc   +1 more source

The mTOR/Akt pathway is involved in regulating astrocyte growth and GLT-1 expression during cerebral ischemia-reperfusion. [PDF]

PLoS One
Li Q, Yu Y, Deng H, Li B, Zhao H, Lei D, Li M, Xie S, Yu J, Zhao Y, Yin S, Ji Y.   +11 more
europepmc   +1 more source

Cepharanthine inhibits lysosomes and induces apoptosis in triple‑negative breast cancer cells. [PDF]

Mol Med Rep
Li J, Zhou S, Wang Y, Ou G, Yang D, Shen L.   +5 more
europepmc   +1 more source

Therapeutic potential of asparagus polysaccharide in bladder cancer treatment via modulation of PI3K/AKT/mTOR signaling. [PDF]

Sci Rep
Wang J, Liu H, Li K, Xie Z.
europepmc   +1 more source

A scoping review of imatinib-induced testicular toxicity and male fertility impairment. [PDF]

Front Endocrinol (Lausanne)
Ji X, Ahmad MF, Mokhtar MH, He X, Abdul Karim AK.   +4 more
europepmc   +1 more source

Study on the correlation between Interleukin 4 and febrile seizures. [PDF]

Cytojournal
Xiang X, Wang S, Tang C, Jin H, Lei L, Mao G, Huang X, Huang B.   +7 more
europepmc   +1 more source

FOXO1 in cancer: context-dependent roles, microRNA regulation, and therapeutic opportunities. [PDF]

Discov Oncol
Ngu ICC, Krishnan T, Chu SYC, Ng SK, Mufti H, Alshanon AF, Burgess K, Wong WF, Looi CY.   +8 more
europepmc   +1 more source

rRGD3^mu, a Triple-RGD Recombinant Peptide, Suppresses Malignant Phenotypes in Nasopharyngeal Carcinoma-Associated Models Through the Modulation of ITGB1-Associated FAK/AKT Signaling. [PDF]

Int J Mol Sci
Yuan Q, Zhou F, Li X, Zhang J, Zhang Y, Yao J, Lv M, Wang J, Lv L.   +8 more
europepmc   +1 more source